• OPEN AN ACCOUNT
Indian Indices
Nifty
24,346.70 12.50
(0.05%)
Sensex
80,501.99 259.75
( 0.32%)
Bank Nifty
55,115.35 28.20
( 0.05%)
Nifty IT
35,891.85 96.90
( 0.27%)
Global Indices
Nasdaq
41,337.14 563.18
(1.38%)
Dow Jones
5,708.24 83.10
(1.48%)
Hang Seng
36,831.70 379.40
(1.04%)
Nikkei 225
8,596.35 99.55
(1.17%)
Forex
USD-INR
84.62 -0.14
(-0.16%)
EUR-INR
95.64 -0.64
(-0.67%)
GBP-INR
112.53 -0.71
(-0.62%)
JPY-INR
0.59 -0.01
(-1.42%)

EQUITY - MARKET SCREENER

Aarti Drugs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524348
INE767A01016
126.1755588
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AARTIDRUGS
24.33
3209.45
EPS(TTM)
Face Value()
Div & Yield %
14.35
10
0.29
 

muthoot finance ltd
GAIL (India) signs MoU with CONCOR
Apr 26,2025

GAIL (India) and Container Corporation Of India (CONCOR) have signed a Memorandum of Understanding (MoU) to explore the adoption of Liquefied Natural Gas (LNG) as an alternative fuel for the logistics sector. The MoU was signed on 23 April 2025, in New Delhi.

The MoU aims to assess the feasibility of using LNG as fuel for CONCOR's logistics fleet. This collaboration seeks to harness LNG's advantages as a cleaner and more cost-effective alternative to diesel, which could result in reduced emissions and lower operational costs. The agreement underscores India's growing commitment to sustainable practices and energy efficiency in the logistics sector through the adoption of alternative fuels.